Raymond James & Associates Sells 13,645 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Raymond James & Associates trimmed its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 7.2% in the third quarter, Holdings Channel reports. The fund owned 176,121 shares of the financial services provider’s stock after selling 13,645 shares during the quarter. Raymond James & Associates’ holdings in iShares Biotechnology ETF were worth $25,643,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors also recently made changes to their positions in IBB. Future Financial Wealth Managment LLC bought a new position in iShares Biotechnology ETF during the first quarter worth $27,000. Bbjs Financial Advisors LLC acquired a new stake in iShares Biotechnology ETF in the 2nd quarter worth $31,000. Chris Bulman Inc bought a new position in shares of iShares Biotechnology ETF during the 2nd quarter worth about $64,000. BNP Paribas acquired a new position in shares of iShares Biotechnology ETF during the first quarter valued at about $69,000. Finally, Financial Perspectives Inc lifted its stake in shares of iShares Biotechnology ETF by 23.3% in the first quarter. Financial Perspectives Inc now owns 519 shares of the financial services provider’s stock valued at $71,000 after buying an additional 98 shares during the period. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Price Performance

IBB stock opened at $141.59 on Friday. iShares Biotechnology ETF has a twelve month low of $111.83 and a twelve month high of $150.57. The business’s 50-day simple moving average is $145.62 and its 200 day simple moving average is $139.93.

iShares Biotechnology ETF Announces Dividend

The company also recently disclosed a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were issued a dividend of $0.2005 per share. The ex-dividend date of this dividend was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.